Institutional Investor's Anti-Per Se Technologies Inc (NASDAQ:PSTI) Sentiment In Q4 2018 - Invest Tribune

Institutional Investor's Anti-Per Se Technologies Inc (NASDAQ:PSTI) Sentiment In Q4 2018  Invest Tribune

Per Se Technologies Inc (NASDAQ:PSTI) institutional sentiment decreased to 0.82 in 2018 Q4. Its down -0.08, from 0.9 in 2018Q3. The ratio has worsened, as 9 ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more